Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publication and briefly summarized - that is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2023

    read more

    Edition 3/2023

    read more

    Edition 2/2023

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Esophagus to Small Intestine

    Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn’s disease: A GETAID multicenter cohort study

    Aliment Pharmacol Ther. 2023;57(4):426–34

    Fumery M, Defrance A, Roblin X, Altwegg R, Caron B, Hébuterne X, Stefanescu C, Meyer A, Nachury M, Laharie D, Nancey S, Le Berre C, Serrero M, Geyl S, Giletta C, Ah-Soune P, Duveau N, Uzzan M, Abitbol V, Biron A, Tran-Minh ML, Paupard T, Vuitton L, Elgharabawy Y, Peyrin-Biroulet L

    Go to article

    Esophagus to Small Intestine

    Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn’s disease

    Clin Gastroenterol Hepatol. 2023;21(1):153–63.e12

    Kucharzik T, Wilkens R, D’Agostino MA, Maconi G, Le Bars M, Lahaye M, Bravatà I, Nazar M, Ni L, Ercole E, Allocca M, Machková N, de Voogd FAE, Palmela C, Vaughan R, Maaser C; STARDUST Intestinal Ultrasound study group

    Go to article

    Esophagus to Small Intestine

    Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: When the remission state hides different types of residual disease activity

    Gut. 2023;72(3):443–50

    Pierre N, Huynh-Thu VA, Marichal T, Allez M, Bouhnik Y, Laharie D, Bourreille A, Colombel JF, Meuwis MA, Louis E; GETAID (Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif)

    Go to article

    Esophagus to Small Intestine

    Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: Systematic review and network meta-analysis

    Gut. 2023;72(2):264–74

    Barberio B, Gracie DJ, Black CJ, Ford AC

    Go to article

    Esophagus to Small Intestine

    Top-down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease

    Inflamm Bowel Dis. 2023;29(2):185–94

    Buisson A, Blanco L, Manlay L, Reymond M, Dapoigny M, Rouquette O, Dubois A, Pereira B

    Go to article

    Colon to Rectum

    Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): A prospective, multicenter cohort study

    Lancet Gastroenterol Hepatol. 2023;8(1):31–42

    Atia O, Shavit-Brunschwig Z, Mould DR, Stein R, Matar M, Aloi M, Ledder O, Focht G, Urlep D, Hyams J, Broide E, Weiss B, Levine J, Russell RK, Turner D

    Go to article

    Colon to Rectum

    Rapid and sustained symptom relief in patients with ulcerative colitis treated with filgotinib: Data from the phase 2b/3 SELECTION trial

    Am J Gastroenterol. 2023;118(1):138–47

    Danese S, Ferrante M, Feagan BG, Peyrin-Biroulet L, Hibi T, Sandborn WJ, Schreiber S, Ritter T, Loftus EV, Jr., Rogler G, Oortwijn A, Yun C, Le Brun FO, Dinoso J, Hsieh J, Vermeire S

    Go to article

    Colon to Rectum

    Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF-experienced ulcerative colitis patients: A nationwide Dutch Registry study

    Clin Gastroenterol Hepatol. 2023;21(1):182–91.e2

    Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis

    Go to article

    Colon to Rectum

    Early management of acute severe UC in the biologics era: Development and international validation of a prognostic clinical index to predict steroid response

    Gut. 2023;72(3):433–42

    Adams A, Gupta V, Mohsen W, Chapman TP, Subhaharan D, Kakkadasam Ramaswamy P, Kumar S, Kedia S, McGregor CGC, Ambrose T, George BD, Palmer R, Brain O, Walsh A, Ahuja V, Travis SPL, Satsangi J

    Go to article